Previous Article in Journal
Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmonary Disease? What Do We Need to Add?
Article Menu

Export Article

Open AccessReview
Med. Sci. 2018, 6(2), 51; https://doi.org/10.3390/medsci6020051

Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis

1
Unit of Interstitial Lung Diseases, Pneumology Service, Hospital General Universitario, 46014 Valencia, Spain
2
Hospital Sant Francecs de Borja, Gandía, 46702 Valencia, Spain
*
Author to whom correspondence should be addressed.
Received: 23 May 2018 / Accepted: 11 June 2018 / Published: 14 June 2018
(This article belongs to the Special Issue Idiopathic Pulmonary Fibrosis)
View Full-Text   |   Download PDF [251 KB, uploaded 14 June 2018]

Abstract

Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias. With a median survival of 3–5 years following diagnosis, IPF is characterized by a progressive decline in lung function and quality of life in most patients. Prognostic factors recognized classically that influence mortality include functional, clinical and radiological parameters. However, in recent years, there has also been progress in the knowledge of genetic factors and biomarkers that may be useful in the prognostic evaluation of these patients. On the other hand, the monitoring of the disease throughout its evolution is key to improving the prognosis of the patients, as it allows for taking therapeutic measures based on this evolution, even early remission for lung transplantation. This article reviews the main prognostic factors of the disease, as well as the most useful way to monitor the disease follow-up. View Full-Text
Keywords: idiopathic pulmonary fibrosis; prognostic factors; monitoring; follow-up idiopathic pulmonary fibrosis; prognostic factors; monitoring; follow-up
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Fernández Fabrellas, E.; Peris Sánchez, R.; Sabater Abad, C.; Juan Samper, G. Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis. Med. Sci. 2018, 6, 51.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Med. Sci. EISSN 2076-3271 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top